Chargement en cours...
Lu-177 labelled peptide treatment for radioiodine refractory differentiated thyroid carcinoma
Differentiated thyroid carcinoma (DTC) has good prognosis but 5% of the patients already have distant metastasis at the diagnosis. Tumour cells can lose their iodine uptake ability and enter a state of dedifferentiation. Treatment for differentiated thyroid carcinoma that is not suitable for the loc...
Enregistré dans:
| Publié dans: | BMJ Case Rep |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Publishing Group
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4785463/ https://ncbi.nlm.nih.gov/pubmed/26957032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2015-213627 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|